Example user scenarios for consideration when architecting path quality testing (baseline and/or pathfinder) Rare diseases Parkinson's (see below) Dihydropyridine calcium channel blockers Input: Parkinson's - Queries: What chemicals may decrease the activity of [APLP1](https://www.ncbi.nlm.nih.gov/gene/333) - Queries: What chemicals may decrease the activity of [LAG3](https://www.ncbi.nlm.nih.gov/gene/3902) - Expect Output: - References: [Parkinson's](https://www.sciencealert.com/parkinsons-discovery-suggests-we-may-already-have-an-fda-approved-treatment), [Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein](https://link.springer.com/article/10.1038/s41467-024-49016-3)
Example user scenarios for consideration when architecting path quality testing (baseline and/or pathfinder)
Rare diseases
Parkinson's (see below)
Dihydropyridine calcium channel blockers
Input: Parkinson's